MCMCB Pro
D17.30

D17.30Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites

Billable / specific codeICD-10-CM

D17.30 is a billable, specific ICD-10-CM code for benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites. It is valid for submission on a claim.

Risk adjustment

D17.30 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.

Medicare coverage

D17.30 is named in 5 Medicare coverage policies 5 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

  • A56695Billing and Coding: Implantable Infusion Pump
  • A57452Billing and Coding: Peripheral Nerve Blocks
  • A57452Billing and Coding: Peripheral Nerve Blocks
  • A57788Billing and Coding: Peripheral Nerve Blocks

How D17.30 is indexed

Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to D17.30.

  • Lipomasite classificationconnective tissue
  • Lipomasite classificationskin
  • Lipomasite classificationsubcutaneous

Related codes at this level

Codes that share D17.3. If D17.30 is not quite right, the correct code is usually one of these.

Questions about D17.30

Is D17.30 a billable ICD-10-CM code?
Yes. D17.30 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does D17.30 sit in the tabular list?
Neoplasms (C00-D49), in the block Benign neoplasms, except benign neuroendocrine tumors (D10-D36).
ICD-10-CMFY2026-Apr· effective April 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release — see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.